Body Weight Change in Non-small Cell Lung Cancer Patients Treated With EGFR-TKI | Zendy

Takahide Kodama | Zendy; Shinya Sato | Zendy; Kunihiko Miyazaki | Zendy; Shinichiro Okauchi | Zendy; Yuika Sasatani | Zendy; Gen Ohara | Zendy; Katsunori Kagohashi | Zendy; Hiroaki Satoh | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Body Weight Change in Non-small Cell Lung Cancer Patients Treated With EGFR-TKI

Author(s) -

Takahide Kodama,

Shinya Sato,

Kunihiko Miyazaki,

Shinichiro Okauchi,

Yuika Sasatani,

Gen Ohara,

Katsunori Kagohashi,

Hiroaki Satoh

Publication year - 2022

Publication title -

cancer diagnosis and prognosis

Language(s) - English

Resource type - Journals

ISSN - 2732-7787

DOI - 10.21873/cdp.10119

Subject(s) - medicine , lung cancer , medical record , body weight , weight loss , weight change , retrospective cohort study , tyrosine kinase inhibitor , cancer , gastroenterology , obesity

Body weight (BW) changes in epidermal growth factor inhibitor-tyrosine kinase (EGFR-TKI) treated non-small cell lung cancer patients has yet to be fully investigated. For the purpose of clarifying changes in body weight in patients who received EGFR-TKI treatment in clinical practice, we performed a retrospective study. In this study, comparison between pretreatment BW and those at 12, 24 weeks, and 12 months in these patients was performed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research